Table 2.
Coronavirus subgroup | Analyte | Assay method | Detection time | Concentration range | Limit of detection | Tested sample | Reference |
---|---|---|---|---|---|---|---|
SARS-CoV | Oligonucleotide | Electrochemical (SWV) | 2 h 10 min | 0.01–1.01 nM | 6 pM | Spiked oligonucleotide solutions | [100] |
SARS-CoV | Oligonucleotide | Electrochemical (CA) | 3 h 25 min | – | 8 pM | Spiked oligonucleotide solutions | [102] |
Electrochemical (CV) | 1 h 30 min | 0.5 nM | |||||
SARS-CoV | Oligonucleotide | Electrochemical (CV) | 2 h 20 min | 2.5–50 pM | 2.5 pM | Spiked oligonucleotide solutions | [101] |
SARS-CoV | Oligonucleotide | Electrochemical (SWV) | 3 h | 0.1–10 nM | – | Spiked oligonucleotide solutions | [103] |
SARS-CoV | Oligonucleotide | Optical (colorimetry) | 5 min | – | < 100 fmol | Spiked oligonucleotide solutions | [107] |
SARS-CoV | RNA | Optical (SPR) | ~ 2 h | – | 2 nM | Throat swab samples | [37] |
MERS-CoV | RNA | Optical (fluorescence) | 30 min | – | 0.1 pM | Pseudo-serum samples | [104] |
MERS-CoV | Oligonucleotide | Optical (colorimetry) | – | 20–1000 nM | 1.53 nM | Spiked oligonucleotide solutions | [106] |
MERS-CoV | Oligonucleotide | Optical (colorimetry) | 10 min | – | 1 nM | Spiked oligonucleotide solutions | [105] |
SARS-CoV-2 | Oligonucleotide | Optical (LSPR and PPT) | ~ 14 min | – | 0.22 pM | Spiked oligonucleotide solutions | [24] |
SWV, square-wave voltammetry; CA, chronoamperometry; CV, cyclic voltammetry; SPR, surface plasmon resonance; SMR, silicon microring resonator; LSPR, localized surface plasmon resonance; PPT, plasmonic photothermal effect